Cefdinir Powder, For Suspension
Product Images NDC 65862-218

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 65862-218). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cefdinir-fig1 (Cefdinir Fig1)

This is a prescription medication called Cefdinir for Oral Suspension, USP in a 125 mg/5 mL concentration, reconstituted with 38 mL water to provide 60 mL of suspension. The medication is used to treat infections in children of certain ages and weights, and the package enclosure contains more specific prescribing information. The medication should be used within 40 days after mixing and stored at room temperature between 20° to 25°C (68° to 77°F). The bottle should be kept tightly closed and shaken well before each use. This medication is distributed by Aurobindo Pharma USA, Inc.*

FDA Label Image

Cefdinir-fig2 (Cefdinir Fig2)

This is a label for a medicine bottle of Cefdinir oral suspension, with a strength of 125 mg/5 mL. The bottle contains 60 doses of the suspension, and each dose requires reconstitution with 38mL of water. The suspension must be shaken well before use, and any unused portion must be discarded within 10 days after mixing. The label also includes details such as the manufacturer's name and the National Drug Code (NDC) number.*

FDA Label Image

Cefdinir-fig3 (Cefdinir Fig3)

Each 5 mL of reconstituted suspension contains 250 mg cefdinir USP. The dosage varies based on age, weight, and type of infection. The suspension is prepared by adding powder and water, shaking well before each use. The reconstituted suspension and dry powder should be stored at a temperature of 20° to 25°C (68° to 77°F). The suspension must be used within 10 days of mixing and any unused portion should be discarded. This medication is manufactured and distributed by Aurobindo Pharma USA, Inc. and is available by prescription only. For full prescribing information, please refer to the package enclosure.*

FDA Label Image

Cefdinir-fig4 (Cefdinir Fig4)

This is a description of a medication called 'Cefdinir for Oral Suspension, USP'. The medication comes in a bottle with the NDC code 65862-219-60 and contains 250 mg/5 mL of the medication when reconstituted with 38 mL of water. The medication is used to treat bacterial infections and needs to be shaken well before use. The reconstitution of the medication must be done at the time of opening and any unused portion must be discarded within 10 days after mixing. This medication is manufactured by Aurobindo.*

FDA Label Image

Chemical Structure (Cefdinir Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.